重组人血管内皮抑制素联合复方苦参注射液腹腔 灌注治疗消化道肿瘤恶性腹腔积液的疗效观察.

MLA

宋树玺, et al. “重组人血管内皮抑制素联合复方苦参注射液腹腔 灌注治疗消化道肿瘤恶性腹腔积液的疗效观察. (Chinese).” Evaluation & Analysis of Drug-Use in Hospitals of China, vol. 24, no. 9, Sept. 2024, pp. 1093–96. EBSCOhost, https://doi.org/10.14009/j.issn.1672-2124.2024.09.016.

APA

宋树玺, 徐　龙, 刘军灵, 李静玉, & 郑振东. (2024). 重组人血管内皮抑制素联合复方苦参注射液腹腔 灌注治疗消化道肿瘤恶性腹腔积液的疗效观察. (Chinese). Evaluation & Analysis of Drug-Use in Hospitals of China, 24(9), 1093–1096. https://doi.org/10.14009/j.issn.1672-2124.2024.09.016

Chicago

宋树玺, 徐　龙, 刘军灵, 李静玉, and 郑振东. 2024. “重组人血管内皮抑制素联合复方苦参注射液腹腔 灌注治疗消化道肿瘤恶性腹腔积液的疗效观察. (Chinese).” Evaluation & Analysis of Drug-Use in Hospitals of China 24 (9): 1093–96. doi:10.14009/j.issn.1672-2124.2024.09.016.